INFU

InfuSystems Holdings Inc. Common Stock (INFU)

Stock · AMEX · Health Care

$13.39as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

INFU Shares Business Overview, Emphasizes Patient-First Strategy. INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.

Active signals

Support level
$8.79
Industry
Medical/Dental Instruments

What INFU's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike42-1.9%40%
Bollinger Band Breakdown20-0.3%40%
Bollinger Band Breakout18-0.9%44%
200-Day Moving Average TouchActive now16-1.4%44%
Any 20-session window (baseline)-0.6%47%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About INFU

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, i…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
461

Fundamentals

1-day range
$13.69$14.02
Market cap
$236.42M
P/E (trailing)
31.71
P/E (forward)
26.77
EPS (trailing)
$0.41
Dividend yield
—
Beta
1.42
Avg. volume
139.1K
52-week range
$7.29$13.85
Next earnings: November 3, 2026 · EPS estimate $0.12Before Openconfirmed

How InfuSystems Holdings Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$143.44MNet Income$6.63M (5%)SG&A$67.46M (47%)Cost of Revenue$63.14M (44%)Tax$4.00M (3%)Other$2.22M (2%)INFU

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$80.30M(56%)
Operating Income$11.92M(8%)

Forecasts

3 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$18
+34.4%
Median
$17.5
+30.7%
Low
$15
+12.0%

InfuSystems Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • INFU
    InfuSystems Holdings Inc. Common Stock
    $13.4
    ▼ 3.74%
    Market cap $236.42MP/E 31.71
    $7.29$13.85
  • SENS
    Senseonics Holdings Inc. Common Stock
    $7.77
    ▼ 5.59%
    Market cap $215.29MP/E —
    $4.79$10.64
  • PDEX
    Pro-Dex Inc. Common Stock
    $58.26
    ▼ 2.93%
    Market cap $209.06MP/E 14.11
    $23.47$77
  • EMBC
    Embecta Corp. Common Stock
    $6.27
    ▼ 2.79%
    Market cap $207.65MP/E 4.00
    $2.77$14.91
  • ANIK
    Anika Therapeutics Inc. Common Stock
    $19.98
    ▼ 3.43%
    Market cap $269.80MP/E —
    $8.67$22.88
  • OSUR
    OraSure Technologies Inc. Common Stock
    $3.61
    ▼ 5.25%
    Market cap $275.39MP/E —
    $2.08$4.58
  • LUCD
    Lucid Diagnostics Inc. Common Stock
    $0.478
    ▼ 8.08%
    Market cap $193.54MP/E —
    $0.5$1.63

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
93.0K
Disposed
54.9K

Institutional Ownership

March 31, 2026

Total shares held
13.81M
Total value held
$119.88M
Institutional holders
91
Top holders this quarter
  • Unknown1.20M
  • Unknown860.3K
  • Unknown837.9K
  • Unknown721.4K
  • Unknown634.0K
  • Unknown616.6K
  • Unknown594.3K
  • Unknown566.8K
  • Unknown510.0K
  • Unknown473.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.